Steve Pakola serves as Executive at REGENXBIO Inc., where they oversee executive responsibilities. Since joining the company, Steve Pakola has executed 14 insider transactions totaling $788.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved selling 18,247 shares valued at $262.8K.
Steve Pakola currently holds 192,470 shares of REGENXBIO Inc. (RGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steve Pakola has been a net seller of RGNX stock. They have purchased $0 and sold $788.5K worth of shares.
Steve Pakola's most recent insider trade was on Jan 2, 2026, when they sold 18,247 shares at $14.40 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 5, 2024 | RGNX | $286.5K | Option Exercise | 12,878 | $22.25 | Planned |
| Mar 5, 2024 | RGNX | $365.2K | Sale | 12,878 | $28.36 | Planned |
| Jan 3, 2024 | RGNX | $299.8K | Sale | 17,237 | $17.39 | Planned |
| Jan 2, 2024 | RGNX | $0 | Award | 32,051 | $N/A | Planned |
| Jan 2, 2024 | RGNX | $186.4K | Payment | 10,385 | $17.95 | Planned |
| Jan 3, 2023 | RGNX | $69.6K | Sale | 3,138 | $22.17 | Discretionary |
| Jan 3, 2023 | RGNX | $0 | Award | 90,588 | $N/A | Discretionary |
| Jan 3, 2023 | RGNX | $41.7K | Payment | 1,837 | $22.68 | Discretionary |
| Jan 3, 2022 | RGNX | $53.9K | Sale | 1,598 | $33.75 | Discretionary |
| Jan 3, 2022 | RGNX | $0 | Award | 8,900 | $N/A | Discretionary |
| Jan 1, 2022 | RGNX | $37.7K | Payment | 1,152 | $32.70 | Discretionary |
| Jan 4, 2021 | RGNX | $0 | Award | 11,000 | $N/A | Discretionary |